Disposition of fullerene C60 in rats following intratracheal or intravenous administration

References

• Baker GL, Gupta A, Clark ML, et al. (2008). Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol Sci 101:122–31.
   PubMed Web of Science ®Google Scholar
• Bleeker EAJ, de Jong WH, Geertsma RE, et al. (2013). Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharm 65:119–25.
   PubMed Web of Science ®Google Scholar
• Bogdanovic G, Djordjevic A. (2016). Carbon nanomaterials: biologically active fullerenes derivatives. Srh Arh Celok Lek 144:222–31.
   PubMed Web of Science ®Google Scholar
• Bullard-Dillard R, Creek KE, Scrivens WA, Tour JM. (1996). Tissue sites of uptake of 14C-labeled C60. Bioorganic Chemistry 24:376–85.
   Web of Science ®Google Scholar
• Cha C, Shin SR, Annabi N, et al. (2013). Carbon-based nanomaterials: multi-functional materials for biomedical engineering. ACS Nano 7:2891–7.
   PubMed Web of Science ®Google Scholar
• Contado C. (2015). Nanomaterials in consumer products: a challenging analytical problem. Front Chem 3:48.
   PubMed Web of Science ®Google Scholar
• Djordjevic A, Injac R, Jovic D, et al. (2014). Bioimpact of carbon nanomaterials. In: Advanced Carbon Materials Technology. Tiwari A and Shukla SK (eds). Beverly, MA: Scrivener Publishing LLC. 2014; 193–272.
   Google Scholar
• Elshater A-EA, Haridy MAM, Salman MMA, et al. (2018). Fullerene C60 nanoparticles ameliorated cyclophosphamide-induced hepatotoxicity in rats. Biomed Pharmacother 97:53–9.
   PubMed Web of Science ®Google Scholar
• European Commission (2011). Commission recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU). Off J Eur Union L275:38–40.
   Google Scholar
• Ferin J, Oberdörster G, Penney DP, et al. (1990). Increased pulmonary toxicity of ultrafine particles? I. Particle clearance, translocation, and morphology. J Aerosol Sci 21:381–4.
   Web of Science ®Google Scholar
• Fujita K, Morimoto Y, Ogami A, et al. (2009). Gene expression profiles in rat lung after inhalation exposure to C(60) fullerene particles. Toxicology 258:47–55.
   PubMed Web of Science ®Google Scholar
• Gharbi N, Pressac M, Hadchouel M, et al. (2005). [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 5:2578–85.
   PubMed Web of Science ®Google Scholar
• Gwinn MR, Vallyathan V. (2006). Nanoparticles: health effects-pros and cons. Environ Health Perspect 114:1818–25.
   PubMed Web of Science ®Google Scholar
• Halford B. (2006). Fullerene for the face. Chem Eng News 84:47.
   Web of Science ®Google Scholar
• Harmsen AG, Muggenburg BA, Snipes MB, Bice DE. (1985). The role of macrophages in particle translocation from lungs to lymph nodes. Science 230:1277–80.
   PubMed Web of Science ®Google Scholar
• Hendren CO, Mesnard X, Dro¨Ge J, Wiesner MR. (2011). Estimating production data for five engineered nanomaterials as a basis for exposure assessment. Environ Sci Technol 45:2562–9.
   PubMed Web of Science ®Google Scholar
• Hirsch A. (2010). The era of carbon allotropes. Nat Mater 9:868–71.
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison GR, Christensen FM, et al. (2010). The biological mechanisms and physiochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci 114:162–82.
   PubMed Web of Science ®Google Scholar
• Kessler R. (2011). Engineered nanoparticles in consumer products: understanding a new ingredient. Environ Health Perspect 119:A120–5.
   PubMed Web of Science ®Google Scholar
• Kroto HW, Allaf AW, Balm SP. (1991). C60: buckminsterfullerene. Chem Rev 91:1213–35.
   Web of Science ®Google Scholar
• Longmire M, Choyke PL, Kobayashi H. (2008). Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703–17.
   PubMed Web of Science ®Google Scholar
• Mercer RR, Scabilloni JF, Hubbs AF, et al. (2013). Extrapulmonary transport of MWCNT following inhalation exposure. Part Fibre Toxicol 10:13.
   PubMed Web of Science ®Google Scholar
• Mercer RR, Scabilloni J, Wang L, et al. (2008). Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol 294:L87–97.
   PubMed Web of Science ®Google Scholar
• Murr LE, Esquivel EV, Bang JJ, et al. (2004). Chemistry and nanoparticulate compositions of a 10,000 year-old ice core melt water. Water Res 38:4282–96.
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science 311:622–7.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Ferin J, Lehnert BE. (1994). Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102:173–9.
   PubMed Web of Science ®Google Scholar
• Park E-J, Kim H, Kim Y, et al. (2010). Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicol Appl Pharmacol 244:226–33.
   PubMed Web of Science ®Google Scholar
• Riviere J. (2009). Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Nanomed Nanobiotechnol 1:1–148.
   Web of Science ®Google Scholar
• Sayers BC, Germolec DR, Walker NJ, et al. (2016a). Respiratory toxicity and immunotoxicity evaluations of microparticle and nanoparticle C60 fullerene aggregates in mice and rats following nose-only inhalation for 13 weeks. Nanotoxicology 10:1458–68.
   PubMed Web of Science ®Google Scholar
• Sayers BC, Walker NJ, Roycroft JH, et al. (2016b). Lung deposition and clearance of microparticle and nanoparticle C60 fullerene aggregated in B6C3F1 mice and Wistar Han rats following nose-only inhalation for 13 weeks. Toxicology 339:87–96.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW. Jr. (2009). Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–23.
   PubMed Web of Science ®Google Scholar
• Singh R, Pantarotto D, Lacerda L, et al. (2006). Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 103:3357–62.
   PubMed Web of Science ®Google Scholar
• Stanley SC, Tkach AV, Shurin MR, et al. (2012). Pulmonary exposure to graphene oxide and fullerenes causes inflammation and modifies the immune response. Toxicologist 126:145.
   Google Scholar
• Terrones H, Mackay AL. (1992). The geometry of hypothetical curved graphite structures. Carbon 30:1251–60.
   Web of Science ®Google Scholar
• Wang Z, Xuepeng L, Wenmin W, et al. (1998). Fullerenes in the fossil of dinosaur egg. Fullerene Sci Technol 6:715–20.
   Google Scholar
• Yamago S, Tokuyama H, Nakamura E, et al. (1995). In vivo biological behaviour of a water-miscible fullerene: 14C-labelling, absorption, distribution, excretion, and acute toxicity. Chem Biol 2:289–385.
   Google Scholar